Darrell R. Borger, Ph.D.
Affiliations: | 2001 | University of South Carolina, Columbia, SC |
Area:
Cell Biology, PathologyGoogle:
"Darrell Borger"Parents
Sign in to add mentor| Kim E. Creek | grad student | 2001 | University of South Carolina | |
| (Acquired resistance to retinoic acid correlates to altered transforming growth factor-beta signaling during late premalignant states of HPV16-mediated transformation of human keratinocytes.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chaudhary S, Kwak EL, Hwang KL, et al. (2020) Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET-Amplified Esophagogastric Cancers. The Oncologist |
| Shih DJH, Nayyar N, Bihun I, et al. (2020) Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma. Nature Genetics |
| Tanaka S, Batchelor TT, Iafrate AJ, et al. (2019) PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma. Acta Neuropathologica Communications. 7: 66 |
| Voss MH, Hierro C, Heist RS, et al. (2019) A Phase I, Multicenter, Dose-Escalation Study of the Oral Selective FGFR inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring FGFR Gene Alterations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Nayyar N, White MD, Gill CM, et al. (2019) L265P mutation and loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas. Blood Advances. 3: 375-383 |
| Brunner AM, Neuberg DS, Wander SA, et al. (2018) Isocitrate dehydrogenase 1 and 2 mutations, 2-hydroxyglutarate levels, and response to standard chemotherapy for patients with newly diagnosed acute myeloid leukemia. Cancer |
| Mitra D, Clark JW, Shih HA, et al. (2018) Enrichment of Amplification in Brain Metastases from Primary Gastrointestinal Malignancies. The Oncologist |
| Kamran SC, Clark JW, Zheng H, et al. (2018) Primary tumor sidedness is an independent prognostic marker for survival in metastatic colorectal cancer: Results from a large retrospective cohort with mutational analysis. Cancer Medicine |
| Hong TS, Hwang KL, Clark JW, et al. (2018) MET-amplification (MET-amp) in relation to aggressive biology in esophagogastric cancer (EGC): An analysis of clinical outcomes of MET-amp vs non-MET-amp EGC. Journal of Clinical Oncology. 36: 74-74 |
| Hong TS, Wo JY, Ryan DP, et al. (2018) Phase Ib study of neoadjuvant chemoradiation (CRT) with midostaurin, 5-fluorouracil (5-FU) and radiation (XRT) for locally advanced rectal cancer: Sensitization of RAS mutant tumors. Journal of Clinical Oncology. 36: e15674-e15674 |